Boston Scientific (BSX) Assets Average (2009 - 2026)

Boston Scientific has disclosed Assets Average across 18 years of filings, most recently posting $44.0 billion for Q1 2026.

• Assets Average for Q1 2026 came in at $44.0 billion, up 10.67% year-over-year; the trailing twelve-month figure through Mar 2026 was $44.0 billion (up 10.67% YoY), and the FY2025 annual result was $41.5 billion, up 11.45% from the prior year.
• Assets Average came in at $44.0 billion for Q1 2026 at Boston Scientific, up from $43.2 billion in the prior quarter.
• In the past five years, Assets Average ranged from a high of $44.0 billion in Q1 2026 to a low of $32.1 billion in Q3 2022.
• The 5-year median for Assets Average is $35.9 billion (2024), against an average of $36.6 billion.
• Across the five-year window, Assets Average grew 0.48% in 2022 and rose 12.08% in 2025, its largest moves.
• Boston Scientific's Assets Average stood at $32.2 billion in 2022, then rose by 7.39% to $34.6 billion in 2023, then gained by 11.99% to $38.7 billion in 2024, then climbed by 11.5% to $43.2 billion in 2025, then gained by 1.9% to $44.0 billion in 2026.
• The last three Assets Average figures came in at $44.0 billion (Q1 2026), $43.2 billion (Q4 2025), and $42.1 billion (Q3 2025), per Business Quant data.